about
Synthesis and in vitro and in vivo evaluation of 18F-labeled positron emission tomography (PET) ligands for imaging the vesicular acetylcholine transporterRadiosynthesis and in vivo evaluation of [11C]MP-10 as a PET probe for imaging PDE10A in rodent and non-human primate brainRadiosyntheses and in vivo evaluation of carbon-11 PET tracers for PDE10A in the brain of rodent and nonhuman primateSynthesis, [¹⁸F] radiolabeling, and evaluation of poly (ADP-ribose) polymerase-1 (PARP-1) inhibitors for in vivo imaging of PARP-1 using positron emission tomography.Quantitative receptor-based imaging of tumor proliferation with the sigma-2 ligand [(18)F]ISO-1.Radiolabeled isatin binding to caspase-3 activation induced by anti-Fas antibody.New N-substituted 9-azabicyclo[3.3.1]nonan-3alpha-yl phenylcarbamate analogs as sigma2 receptor ligands: synthesis, in vitro characterization, and evaluation as PET imaging and chemosensitization agents.Development of (18)F-labeled PET probes for imaging cell proliferation.Synthesis and evaluation of a bromine-76-labeled PPARgamma antagonist 2-bromo-5-nitro-N-phenylbenzamide.Carbon-11 labeled papaverine as a PET tracer for imaging PDE10A: radiosynthesis, in vitro and in vivo evaluation.Endogenous dopamine (DA) competes with the binding of a radiolabeled D₃ receptor partial agonist in vivo: a positron emission tomography studyEffect of administration route on FES uptake into MCF-7 tumors.Fluorine-18-labeled benzamide analogues for imaging the sigma2 receptor status of solid tumors with positron emission tomography.Preclinical pharmacokinetic, antitumor and toxicity studies with CI-994 (correction of CL-994) (N-acetyldinaline)Comparison of animal models for the evaluation of radiolabeled androgensComparative studies of Cu-64-ATSM and C-11-acetate in an acute myocardial infarction model: ex vivo imaging of hypoxia in ratsSynthesis, radiolabeling, and in vivo evaluation of an 18F-labeled isatin analog for imaging caspase-3 activation in apoptosis
P50
Q24650088-91619C33-8521-47F8-98D6-635A9C5C891DQ28386823-EC9E485A-37D6-458D-8791-6E640104503CQ28387761-1EA4A4A1-E903-4695-A88F-CA23D89EF534Q33607384-705CC3EA-9786-46FF-9334-AF9CAEA243BAQ35000636-6CA88257-4201-4420-BBE2-F4831CB2794FQ35659059-6630E8CF-415D-4631-9E4D-4EE3B9C95A4DQ37161130-A585A317-D329-4830-98B7-5BF9C7810EF4Q38099370-606E54B0-E704-4C00-9ACB-7BBC4DCD6881Q40219667-43806DEF-7D07-43EF-A349-ED48613C03B1Q40424916-480C1850-2BAB-4DFB-ABAB-EC6F6F3FE37DQ42745808-53188610-B8EC-4C7B-8FEE-2BF7C638C79BQ43632020-D6E87D20-CC1B-41B2-90E4-92B7C65429B0Q48131617-DAD9546B-35BE-44DA-B839-2D2BAB7DA7A9Q73916883-12C74742-1CCB-40E2-87FE-15B9224E92A3Q74415078-679211A5-4DE4-40F8-B839-3A63CC89C89CQ74650682-E25DA4BE-1953-470C-8713-04502C6C2282Q80064628-EA7993C7-BAA2-4B60-908E-E3637E66A3F5
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Lynne A. Jones
@ast
Lynne A. Jones
@en
Lynne A. Jones
@es
Lynne A. Jones
@nl
Lynne A. Jones
@sl
type
label
Lynne A. Jones
@ast
Lynne A. Jones
@en
Lynne A. Jones
@es
Lynne A. Jones
@nl
Lynne A. Jones
@sl
prefLabel
Lynne A. Jones
@ast
Lynne A. Jones
@en
Lynne A. Jones
@es
Lynne A. Jones
@nl
Lynne A. Jones
@sl
P106
P1153
35511035600
P31
P496
0000-0003-0235-9538